These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Thistlethwaite JR; Stuart JK; Mayes JT; Gaber AO; Stuart FP Am J Kidney Dis; 1988 Feb; 11(2):94-8. PubMed ID: 3277413 [TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. Ortho Multicenter Transplant Study Group N Engl J Med; 1985 Aug; 313(6):337-42. PubMed ID: 2861567 [TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL Transplantation; 1987 Jan; 43(1):91-5. PubMed ID: 3099442 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL Transplant Proc; 1987 Feb; 19(1 Pt 3):2431-3. PubMed ID: 3079083 [No Abstract] [Full Text] [Related]
8. Anti-rejection therapy in renal transplantation: Use of the monoclonal antibody OKT3. Nicholson ML; Donnelly PK; Veitch PS; Bell PR Nephrol Dial Transplant; 1991; 6(4):275-9. PubMed ID: 1881582 [TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients. Cosimi AB; Jenkins RL; Rohrer RJ; Delmonico FL; Hoffman M; Monaco AP Arch Surg; 1990 Jun; 125(6):781-4; discussion 785. PubMed ID: 2111982 [TBL] [Abstract][Full Text] [Related]
14. OKT3: First-dose safety and success. Cosimi AB Nephron; 1987; 46 Suppl 1():12-8. PubMed ID: 3306421 [TBL] [Abstract][Full Text] [Related]
15. Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection. Hricik DE; Zarconi J; Schulak JA Transplantation; 1989 Feb; 47(2):272-7. PubMed ID: 2493175 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection. Norman DJ; Shield CF; Henell KR; Kimball J; Barry JM; Bennett WM; Leone M Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448 [TBL] [Abstract][Full Text] [Related]
18. OKT3 in the reversal of acute hepatic allograft rejection. Esquivel CO; Fung JJ; Markus B; Iwatsuki S; Gordon RD; Makowka L; Marsh JW; Tzakis AG; Todo S; Starzl TE Transplant Proc; 1987 Feb; 19(1 Pt 3):2443-6. PubMed ID: 3103297 [TBL] [Abstract][Full Text] [Related]
19. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Ascher NL; Stock PG; Bumgardner GL; Payne WD; Najarian JS Surg Gynecol Obstet; 1988 Dec; 167(6):474-84. PubMed ID: 3055368 [TBL] [Abstract][Full Text] [Related]